Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Effects of GLP-1RAs on Specific Inflammatory Skin Diseases While research is still ongoing, early indications are that GLP-1s may offer benefits for inflammatory skin diseases, including: Psoriasis immune dysregulation related to T cells and cytokines leads to systemic inflammation, skin discoloration, and thickening plaques
doi: 10.1016/J.BBI.2017.05.006 36 WangQLiuDSongPZouMH
The FDA-approved prescribing information does not list autoimmune diseases as contraindications, and clinical practice guidelines from the American Diabetes Association do not restrict GLP-1 receptor agonist use in patients with autoimmune disorders
A useful contrast to the recovery-focused approach covered here
